These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 21880400)

  • 1. Design, synthesis and docking studies of quinoline-oxazolidinone hybrid molecules and their antitubercular properties.
    Thomas KD; Adhikari AV; Chowdhury IH; Sandeep T; Mahmood R; Bhattacharya B; Sumesh E
    Eur J Med Chem; 2011 Oct; 46(10):4834-45. PubMed ID: 21880400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis and docking studies of new quinoline-3-carbohydrazide derivatives as antitubercular agents.
    Thomas KD; Adhikari AV; Telkar S; Chowdhury IH; Mahmood R; Pal NK; Row G; Sumesh E
    Eur J Med Chem; 2011 Nov; 46(11):5283-92. PubMed ID: 21907466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis and biological evaluation of novel triazole, urea and thiourea derivatives of quinoline against Mycobacterium tuberculosis.
    Upadhayaya RS; Kulkarni GM; Vasireddy NR; Vandavasi JK; Dixit SS; Sharma V; Chattopadhyaya J
    Bioorg Med Chem; 2009 Jul; 17(13):4681-92. PubMed ID: 19457676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-tubercular agents. Part 6: synthesis and antimycobacterial activity of novel arylsulfonamido conjugated oxazolidinones.
    Kamal A; Shetti RV; Azeeza S; Swapna P; Khan MN; Khan IA; Sharma S; Abdullah ST
    Eur J Med Chem; 2011 Mar; 46(3):893-900. PubMed ID: 21272965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and in vitro antitubercular activity of a series of quinoline derivatives.
    de Souza MV; Pais KC; Kaiser CR; Peralta MA; de L Ferreira M; Lourenço MC
    Bioorg Med Chem; 2009 Feb; 17(4):1474-80. PubMed ID: 19188070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross-docking study on InhA inhibitors: a combination of Autodock Vina and PM6-DH2 simulations to retrieve bio-active conformations.
    Stigliani JL; Bernardes-Génisson V; Bernadou J; Pratviel G
    Org Biomol Chem; 2012 Aug; 10(31):6341-9. PubMed ID: 22751934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of novel antitubercular compounds through hybrid virtual screening approach.
    Muddassar M; Jang JW; Hong SK; Cho YS; Kim EE; Keum KC; Oh T; Cho SN; Pae AN
    Bioorg Med Chem; 2010 Sep; 18(18):6914-21. PubMed ID: 20727773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New quinoline derivatives: synthesis and investigation of antibacterial and antituberculosis properties.
    Eswaran S; Adhikari AV; Chowdhury IH; Pal NK; Thomas KD
    Eur J Med Chem; 2010 Aug; 45(8):3374-83. PubMed ID: 20537437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New 1,3-oxazolo[4,5-c]quinoline derivatives: synthesis and evaluation of antibacterial and antituberculosis properties.
    Eswaran S; Adhikari AV; Ajay Kumar R
    Eur J Med Chem; 2010 Mar; 45(3):957-66. PubMed ID: 20034708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis, biological evaluation and molecular modelling studies of novel quinoline derivatives against Mycobacterium tuberculosis.
    Upadhayaya RS; Vandavasi JK; Vasireddy NR; Sharma V; Dixit SS; Chattopadhyaya J
    Bioorg Med Chem; 2009 Apr; 17(7):2830-41. PubMed ID: 19285414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis of quinoline coupled [1,2,3]-triazoles as a promising class of anti-tuberculosis agents.
    Karthik Kumar K; Prabu Seenivasan S; Kumar V; Mohan Das T
    Carbohydr Res; 2011 Oct; 346(14):2084-90. PubMed ID: 21767828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and in vitro antibacterial activity of novel 3-azabicyclo[3.3.0]octanyl oxazolidinones.
    Bhattarai D; Lee SH; Seo SH; Nam G; Kang SB; Pae AN; Kim EE; Oh T; Cho SN; Keum G
    Chem Biol Drug Des; 2012 Sep; 80(3):388-97. PubMed ID: 22553981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-based design of a novel class of potent inhibitors of InhA, the enoyl acyl carrier protein reductase from Mycobacterium tuberculosis: a computer modelling approach.
    Subba Rao G; Vijayakrishnan R; Kumar M
    Chem Biol Drug Des; 2008 Nov; 72(5):444-9. PubMed ID: 19012578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ring-substituted quinolines as potential anti-tuberculosis agents.
    Vangapandu S; Jain M; Jain R; Kaur S; Singh PP
    Bioorg Med Chem; 2004 May; 12(10):2501-8. PubMed ID: 15110831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New INH-pyrazole analogs: Design, synthesis and evaluation of antitubercular and antibacterial activity.
    Nayak N; Ramprasad J; Dalimba U
    Bioorg Med Chem Lett; 2015 Dec; 25(23):5540-5. PubMed ID: 26520663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, molecular docking study and biological evaluation of new pyrrole scaffolds as potential antitubercular agents for dual targeting of enoyl ACP reductase and dihydrofolate reductase.
    Mahnashi MH; Avunoori S; Gopi S; Shaikh IA; Saif A; Bantun F; Faidah HS; Alhadi AA; Alshehri JH; Alharbi AA; S R PK; Joshi SD
    PLoS One; 2024; 19(5):e0303173. PubMed ID: 38739587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and antitubercular evaluation of novel dibenzo[b,d]furan and 9-methyl-9H-carbazole derived hexahydro-2H-pyrano[3,2-c]quinolines via Povarov reaction.
    Kantevari S; Yempala T; Surineni G; Sridhar B; Yogeeswari P; Sriram D
    Eur J Med Chem; 2011 Oct; 46(10):4827-33. PubMed ID: 21723649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of novel bis-oxazolidinone compounds as potential potent and selective antitubercular agents.
    Ang W; Ye W; Sang Z; Liu Y; Yang T; Deng Y; Luo Y; Wei Y
    Bioorg Med Chem Lett; 2014 Mar; 24(6):1496-501. PubMed ID: 24582981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel Furan Coupled Quinoline Diamide Hybrid Scaffolds as Potent Antitubercular Agents: Design, Synthesis and Molecular Modelling.
    Rajpurohit A; Satyanarayan ND; Pathak L; Ayyanar S; Rishinaradamangalam CR; Shoorapani P
    Med Chem; 2020; 16(4):507-516. PubMed ID: 31483232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis, biological evaluation and 3D QSAR study of 2,4-disubstituted quinolines as anti-tuberculosis agents.
    Patel SR; Gangwal R; Sangamwar AT; Jain R
    Eur J Med Chem; 2015 Mar; 93():511-22. PubMed ID: 25747550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.